Terminal deletion of 11q with significant late-onset combined immune deficiency

J Clin Immunol. 2014 Jan;34(1):114-8. doi: 10.1007/s10875-013-9966-2.

Abstract

Purpose: We report a 45-year old female adult patient with terminal deletion of chromosome 11q resulting in clinical phenotype of late-onset combined immunodeficiency.

Methods: We describe the clinical phenotype and discuss the similarities between our patient and those with chromosome 22q11.2 deletion syndrome. Immunological evaluation included immunoglobulin levels, vaccine responses, number and function of T, NK and B cell subsets and comparative genomic hybridization test of blood and fibroblasts.

Results: The patient suffered from recurrent pneumococcal pneumonia and genital and cutaneous condylomas. She had a history of learning difficulties, dysmorphic features, autoimmune thyroiditis, chronic thrombocytopenia and severe asthma. We found Paris-Trousseau type thrombocytopenia, B-, T- and NK-lymphopenia, T cell oligoclonality and IgG hypogammaglobulinemia with inability to respond to pneumococcal polysaccharide, tetanus and diphtheria vaccines. A terminal deletion of chromosome 11q compatible with partial Jacobsen syndrome was found.

Conclusions: This confirms Jacobsen syndrome as a chromosome deletion syndrome able to cause combined immunodeficiency.

Publication types

  • Case Reports

MeSH terms

  • Age of Onset*
  • Chromosome Deletion*
  • Chromosomes, Human, Pair 11*
  • Diagnosis, Differential
  • Female
  • Humans
  • Jacobsen Distal 11q Deletion Syndrome / diagnosis
  • Middle Aged
  • Phenotype
  • Severe Combined Immunodeficiency / diagnosis*
  • Severe Combined Immunodeficiency / genetics*
  • Severe Combined Immunodeficiency / immunology